US-based Eli Lilly - amongst the top 10 global pharmaceutical companies, with annual revenues of $21.8 billion in 2009 - has planned to continue its focus on innovation-driven products, instead of......
US drug transnational Eli Lilly, which thus far was slow on launching its major drugs in India owing to inadequate patent protection, is now gearing up to launch a new drug every year.Eli Lilly &......
Drug major Eli Lilly will discontinue its animal insulin product Iletin after this year and is planning to conduct trials for "inhaled insulin" in the country."Throughout the world, animal insulin......